¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"brain purpura"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
¿µ¹® brain stem ÇÑ±Û ³úÁÙ±â
¼³¸í   
  ³úÁÙ±âÀ̶õ ´ë³ú¿Í Ã´¼ö¸¦ À̾îÁִ ´Ù¸® ¿ªÇÒÀ» Çϴ ³úÀÇ ºÎºÐÀ¸·Î À̰÷¿¡´Â Áß°£³ú, ´Ù¸®³ú, ¼û³úÀÇ 3°³ÀÇ ºÎºÐÀÌ Æ÷ÇԵȴÙ. À̰÷Àº ´ë³ú¿¡¼­ ³ª°¡´Â ¿îµ¿½Å°æ°ú ´ë³ú·Î µé¾î¿À´Â °¨°¢½Å°æÀÇ Áß¿äÇÑ Åë·Î°¡ Àִ °÷À̸ç, µ¿½Ã¿¡ ´ëºÎºÐÀÇ ³ú½Å°æ(ô¼ö¸¦ °ÅÄ¡Áö ¾Ê°í ³ª°¡´Â ½Å°æ, Áï ³ú¿¡¼­ Á÷Á¢ ³ª¿À°í µé¾î¿À´Â ½Å°æÀ» À̸£´Â ¸»)ÀÇ Áß¿äÇÑ ¿äÁöÀÌ´Ù.
¿µ¹® blood-brain barrier(BBB) ÇÑ±Û Ç÷³úÀ庮
¼³¸í   
  ³ú¿Í Ã´¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ´Ù. À̰ÍÀº ³ú¿Í Ã´¼ö¿¡ Á¸ÀçÇϴ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ºñ±³Àû ´Ù¸¥ ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºº¸´Ù ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
¿µ¹® blood-brain barrier ÇÑ±Û Ç÷¾×³úÀ庮
¼³¸í   
  Ç÷¾×À¸·ÎºÎÅÍ ³ú·Î´Â ÁöÁú¿ëÇØ¼ºÀÌ ³ôÀº ¾à¹°¹Û¿¡ ÀÌÇàµÇÁö ¾Ê´Â´Ù. ¼ö¿ë¼ºÀÇ ¾à¹°À» ³ú·Î ÀÌÇàµÇÁö ¾Ê°Ô Çϰí Àִ °ÍÀÌ Ç÷¾×³úÀ庮À̸砳úÀÇ ¸ð¼¼Ç÷°ü ³»ÇǼ¼Æ÷, ¸ð¼¼Ç÷°ü ÁÖÀ§ÀÇ ¼¼Æ÷°¡ À庮ÀÌ µÇ°í ÀÖ´Ù. ¹°Áú±³È¯Àº ¼öµ¿È®»ê¿¡ ÀÇÇØ ÀÌ·ç¾îÁöÁö¸¸, ³úÀÇ »ý¸®Àû È°µ¿¿¡ ÇÊ¿äÇÑ ¹°ÁúÀº ÀÌ¿ÂÇüÀ̶󵵠´ãü¸¦ ÅëÇØ ÀÌÇàµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • brain stem reflex
    ³úÁÙ±â¹Ý»ç, ³ú°£¹Ý»ç
  • brain vesicle
    ³ú¼ÒÆ÷, ³úÆ÷
  • brain-heart infusion agar
    ³ú½ÉÀåÁó¿ì¹«¹èÁö
  • elective brain irradiation
    ¼±ÅÃÀû³úÁ¶»ç
  • hypoxic brain injury
    Àú»ê¼Ò³ú¼Õ»ó
  • minimal brain dysfunction
    °æ¹Ì³ú±â´ÉÀå¾Ö
  • olfactory brain
    Èİ¢³ú
  • organic brain syndrome
    ±âÁú¼º³úÁõÈıº
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • angioneurotic purpura
    Ç÷°ü½Å°æÀÚ»ö¹Ýº´
  • athrombocytopenic purpura
    ºñÀúÇ÷¼ÒÆÇÀÚ»ö¹Ýº´
  • allergic purpura
    ¾Ë·¹¸£±âÀÚ»ö¹Ýº´
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã½ºÀÚ»ö¹Ýº´
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • dysproteinemic purpura
    ÀÌ»ó´Ü¹éÇ÷ÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minor brain damage
    °æµµ³ú¼Õ»ó
  • elective brain irradiation
    ¿¹¹æ³úÁ¶»ç
  • hypoxic brain injury
    Àú»ê¼Ò³ú¼Õ»ó
  • organic brain syndrome
    ±âÁú³úÁõÈıº
  • primary brain vesicles
    ÀÏÂ÷³úÆ÷
  • allergic purpura
    ¾Ë·¹¸£±âÀÚ»ö¹ÝÁõ
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã½ºÀÚ»ö¹ÝÁõ
  • angioneurotic purpura
    Ç÷°ü½Å°æÀÚ»ö¹ÝÁõ
  • athrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼ºÀÚ»ö¹ÝÁõ
  • bullous purpura
    ¼öÆ÷ÀÚ»ö¹Ý, ¹°ÁýÀÚ»ö¹Ý
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • dysproteinemic purpura
    ÀÌ»ó´Ü¹éÇ÷ÀÚ»ö¹Ý
  • factitious purpura
    ÀΰøÀÚ»ö¹Ý
  • flat purpura
    ÆíÆòÀÚ»ö¹Ý
  • fulminant purpura
    Àü°ÝÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • TTP=£¾thrombotic thrombocytopenic purpura
    Ç÷Àü¼º Ç÷¼ÒÆÇ°¨¼ÒÀÚ¹ÝÁõ.
  • allergic purpura
    ¾Ë·¹¸£±â(¼º) ÀÚ¹ÝÁõ(í¹Úèñø)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»)
  • anaphylactoid purpura
    ¾Æ³ªÇʶô½Ã¾ç Àڹݺ´(¡­í¹ÚèÜ»).
  • annularis telangiectodes purpura
    ¸ð¼¼Ç÷°ü È®À强 ȯ»óÀÚ¹Ý
  • gangrenous purpura
    ±«Àú¼º ÀÚ¹Ý(¡­í¹Úè)
  • hemorrhagic purpura
    ÃâÇ÷(¼º) ÀÚ¹Ý(º´)
  • henoch-schonlein purpura
    Çì³ëÈ£-½¦¶óÀÎ (Henoch-Schonlein) ÀÚ¹ÝÁõ
  • hypergammaglobulinemic purpura
    °ú°¨¸¶±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hyperglobulinemic purpura
    °ú±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hypersplenic purpura
    ºñ±â´ÉÇ×Áø¼º ÀÚ¹Ý(Áõ).
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ°¨¼Ò¼ºÀڹݺ´(¡­úìá³÷ùÊõá´àõí¹ÚèÜ»)
  • idiopathic thrombocytopenic purpura =ITP
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´.
  • idopathic thrombocytopenic purpura
    Ư¹ß¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹ÝÁõ
  • immunologic thrombocytopenic purpura
    ¸é¿ª¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹Ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • factitious purpura
    Àΰø ÀÚ¹Ý(º´)
  • flat purpura
    ÆíÆòÀÚ¹Ý
  • fulminant purpura<³ª> p. fulminans
    Àü°Ý¼º ÀÚ¹Ý(¡­í¹Úè).
  • gangrenous purpura
    ±«Àú¼º ÀÚ¹Ý(¡­í¹Úè)
  • hemorrhagic purpura
    ÃâÇ÷(¼º) ÀÚ¹Ý(º´)
  • henoch-schonlein purpura
    Çì³ëÈ£-½¦¶óÀÎ (Henoch-Schonlein) ÀÚ¹ÝÁõ
  • hypergammaglobulinemic purpura
    °ú°¨¸¶±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hyperglobulinemic purpura
    °ú±Û·ÎºÒ¸°Ç÷¼º ÀÚ¹Ý(º´)
  • hypersplenic purpura
    ºñ±â´ÉÇ×Áø¼º ÀÚ¹Ý(Áõ).
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ°¨¼Ò¼ºÀڹݺ´(¡­úìá³÷ùÊõá´àõí¹ÚèÜ»)
  • idiopathic thrombocytopenic purpura =ITP
    Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´.
  • idopathic thrombocytopenic purpura
    Ư¹ß¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹ÝÁõ
  • immunologic thrombocytopenic purpura
    ¸é¿ª¼º Ç÷¼ÒÆÇ°¨¼Ò¼º ÀÚ¹Ý
  • itching purpura
    °¡·Á¿î ÀÚ¹Ý(º´)
  • necrotic purpura
    ±«»ç¼º ÀÚ¹Ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ATP   1) Adenosine Tri-Phosphate
  2) Autoimmune Thrombocytopenic Purpura
HSP Henoch Schonlein Purpura
ITP Idiopathic(Immune) Thrombocytopenic Purpura
PTP Post-Transfusion Purpura
TTP Thrombotic Thrombocytopenic Purpura
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ITP Immune thrombocytopenic purpura
PTP Post transfusion purpura
SHP Scholein-Henoch purpura
TTP Thrombotic Thrombocytopenic Purpura
TTP-HUS Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • blood-brain barrier
    Ç÷³ú À庮
    ³ú¿Í ô¼ö¿¡´Â Ç÷·ù·ÎºÎÅÍ ¾î¶² ¹°ÁúÀÌ À¯ÀԵǴ °ÍÀ» ¸·´Â À庮ÀÌ Á¸ÀçÇϰí À̰ÍÀ» Ç÷³ú À庮À̶ó ÇÑ´Ù. À̰ÍÀº ³ú¿Í ô¼ö¿¡ Á¸ÀçÇÏ´Â ¸ð¼¼Ç÷°üÀÇ Åõ°ú¼ºÀÌ ´Ù¸¥ ¸ð¼¼Ç÷°ü¿¡ ºñÇØ ¶³¾îÁö±â ¶§¹®ÀÌ´Ù.
  • brain abscess
    ³ú ³ó¾ç
    ³ú ³ó¾çÀº ³ú ½ÇÁú³»¿¡ ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, ¿øÃæ·ùµéÀÇ °¨¿°¿¡ ÀÇÇÏ¿© ¹ß»ýµÇ´Â ±¹ÇÑµÈ È­³ó¼º ÁúȯÀÌ´Ù. 1. ¿øÀÎ : ¿©·¯ Á¾·ùÀÇ ¼¼±Õ, Áø±Õ, È¿¸ð±Õ, ±â»ýÃæ µîÀÌ ³ú ³ó¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç, °ú°Å¿¡´Â ¿¬¼â»ó ±¸±Õ, Æ÷µµ»ó ±¸±Õ, Àå³»±Õ, Æó·Å ±¸±Õ µîÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ̾úÀ¸³ª ±Ù·¡¿¡ ¿Í¼­ Ç×»ýÁ¦ÀÇ ±¤¹üÀ§ÇÑ »ç¿ë, ¸é¿ª°áÇÌÁõ ȯÀÚÀÇ Áõ°¡ µîÀ¸·Î ¼Ò °£±Õ, Çø±â¼º ¿¬¼â»ó ±¸±ÕÀÌ °¡Àå ÈçÇÑ ¿øÀαÕÀ¸·Î µÇ¾úÀ¸¸ç, Nocardia±Õ, Áø±Õ, ±â»ýÃæÀÇ ºóµµµµ ³ô¾ÆÁö°í ÀÖ´Ù. °¨¿° °æ·Î¸¦ º¸¸é ÁßÀÌ¿°À̳ª ºÎºñµ¿¿°¿¡¼­ Á÷Á¢ ¶Ç´Â ³ú ÇÇÁú, ³ú°æ¸·ÀÇ Á¤¸ÆÀ» ÅëÇÏ¿© °¨¿°µÇ°Å³ª µÎºÎÀÇ °üÅë»óÀ̳ª µÎºÎ ¼ö¼úÈÄÀÇ ÇÕº´ÁõÀ¸·Î Ç÷·ù¸¦ ÅëÇÑ ÆÐÇ÷¼º »öÀüÀ» ÅëÇÏ¿© ¶Ç´Â ¾Æ±Þ¼º ¼¼±Õ¼º ½É³»¸·¿°À̳ª ¼±Ãµ¼º ½ÉÀ庴 ±×¸®°í ¸é¿ª±â´ÉÀÌ ÀúÇÏµÈ °æ¿ì¿¡ ÁÖ·Î ¹ß»ýÇϸç, »ó´ç¼ö¿¡¼­´Â °¨¿° °æ·Î¸¦ ¸ð¸£´Â °æ¿ìµµ ÀÖ´Ù. 2. Áõ»ó : ´ëºÎºÐÀÇ ³ú ³ó¾çÀº 20¼¼ ÀÌÀü¿¡ ¹ß»ýµÇ´Âµ¥ ±× ÀÌÀ¯´Â ÀÌ ¿¬·É ±º¿¡¼­ ÁßÀÌ¿°À̳ª Ãà³óÁõÀÇ ºóµµ°¡ ³ôÀ¸¸ç, ¼±Ãµ¼º ½ÉÀ庴¿¡ ±âÀÎµÈ ³ú ³ó¾çÀÌ ÁÖ·Î ¼Ò¾Æ±â¿¡ ¹ß»ýµÇ±â ¶§¹®ÀÌ´Ù. 3´ë 2¿¡¼­ 2´ë 1ÀÇ ºñÀ²·Î ³²ÀÚ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÁßÀÌ¿°¿¡¼­ ¹ß»ýµÈ °æ¿ì¿¡´Â ÁÖ·Î ÃøµÎ¿±¿¡ ¹ß»ýµÇ¸ç °¡²û ÃøµÎ¿±À̳ª ÅÍŰ¾È¿¡µµ »ý±ä´Ù. Ç÷¾×À» ÅëÇÏ¿© ÀüÀÌµÈ °æ¿ì°¡ ÃÖ±Ù Áõ°¡µÇ°í Àִµ¥ ´ëºÎºÐ ´Ù¹ß¼ºÀ̰ųª ±íÀº °÷¿¡ À§Ä¡Çϰí óÀ½ Áø´Ü ½Ã °æ°è°¡ È®½ÇÄ¡ ¾ÊÀº Ư¡ÀÌ ÀÖ¾î ¿¹Èİ¡ ÁÁÁö ¾ÊÀº ÆíÀÌ´Ù. ÁÖ Áõ»óÀ̳ª ½Å°æÇÐÀû ÀÌ»ó Á¤µµ´Â ³ó¾çÀÇ ºÎÀ§, Å©±â, º´¼ÒÀÇ ¼ö, ¿øÀαÕÀÇ µ¶¼º, ÁÖº¯ ³ú ºÎÁ¾ÀÇ Á¤µµ, °¨¿°¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¹ÝÀÀ µî¿¡ µû¶ó ´Ù¸£¸ç ÀϹÝÀûÀ¸·Î ³ú Á¶Á÷ÀÇ ÆÄ±«¿Í Á¾±« È¿°ú¿¡ µû¶ó µÎ°³°­ ³»¾ÐÀÇ »ó½Â°ú ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù. Áõ»ó ¹ßÇö°ú Áø´Ü±îÁöÀÇ ±â°£Àº 75%¿¡¼­ 2ÁÖ À̳»ÀÌ¸ç °¡Àå ÈçÇÑ Áõ»óÀº Á¡Â÷ ½ÉÇØÁö´Â µÎÅëÀ¸·Î 70-95%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª¸ç ÁÖ·Î ¿À½É°ú ±¸Å並 µ¿¹ÝÇÑ´Ù. ¹ßÀÛÀÌ 30-50%ÀÇ È¯ÀÚ¿¡¼­ ³ªÅ¸³ª°í ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­ ¹Ì¿­ÀÌ ³ªÅ¸³ªÁö¸¸ 39µµ ÀÌ»óÀÇ °í¿­Àº µå¹°´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â Çö±âÁõÀ̳ª ÇöÈÆÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. ÀÔ¿ø½Ã ¾à ¹Ý¼öÀÇ È¯ÀÚ¿¡¼­´Â ¹ß¿­ µîÀÇ Àü½Å Áõ»óÀÌ ³ªÅ¸³ª¸ç µÎ°³°­ ³»¾ÐÀÇ »ó½ÂÀ¸·Î 23-50%¿¡¼­ À¯µÎ ºÎÁ¾À» º¼ ¼ö ÀÖ´Ù. ÀÔ¿ø ½Ã¿¡ ¹Ý¼ö À̻󿡼­ ÀÇ½Ä Àå¾Ö°¡ ÀÖÀ¸¸ç °æÇÑ ÀǽÄÀÇ Àå¾Ö·ÎºÎÅÍ È¥¼ö »óűîÁö ¿©·¯ Á¤µµ·Î ³ªÅ¸³­´Ù. óÀ½ ÀǽÄÀÇ Á¤µµ°¡ ȯÀÚÀÇ ¿¹ÈÄ¿¡¼­ °¡Àå Áß¿äÇÏ´Ù. ³ú ÇÇÁúÀ̳ª ³ú ÇÇÁú ÇϺÎÀÇ Æ¯Á¤ÇÑ ºÎÀ§ÀÇ ¼Õ»óÀ¸·Î ±¹¼Ò¼º ½Å°æÇÐÀû Àå¾Ö¸¦ ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¸ç ¹Ý½Å ¸¶ºñ, ¾ð¾îÀå¾Ö, ½Ã¾ß °á¼Õ µîÀ» ÈçÈ÷ º¼ ¼ö ÀÖ´Ù. ¼Ò³ú ³ó¾çÀÇ °æ¿ì¿¡´Â ¼öÆò¼º ¾È±¸ ÁøÅÁ
  • brain center
    ´ë³ú ÁßÃß
  • brain concussion
    ³úÁøÅÁ
    µÎºÎ¿¡ °­ÇÑ ¿Ü·ÂÀÌ ÀÛ¿ëÇÑ Á÷ÈÄ¿¡ ÀϾ´Â Áõ¼¼. µÎºÎ¿¡ ¿Ü·ÂÀÌ ÀÛ¿ëÇÔ°ú µ¿½Ã¿¡ Àϰú¼ºÀÇ ÀÇ½Ä ¼Ò½ÇÀ» ÀÏÀ¸Å°Áö¸¸ ³ú ½ÇÁúÀÇ ÆÄ±«´Â ÀϾÁö ¾ÊÀº »óÅÂÀÌ´Ù. ´Ü½Ã°£
  • brain damage
    ³ú ¼Õ»ó
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • brain function mapping
    ³ú ±â´É ÁöµµÈ­
  • brain injury
    ³ú ¼Õ»ó
  • brain peptide
    ³ú ÆéƼµå
  • brain sand
    ³ú»ç
    ³úÀÇ ÀÏÁ¤ ºÎºÐ¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÛÀº ¸ð·¡ ¸ð¾çÀÇ ´Ü´ÜÇÑ ÀÔÀÚ. ¼®È¸°¡ Ä§ÂøµÇ¾î »ý±ä °ÍÀÌ´Ù. ³ú»ç°¡ ¸ð¿© ÀÖ´Â ºÎÀ§´Â º¸Åë ¼Û°ú¼±°ú ±× ºÎ±ÙÀε¥ ÀþÀº »ç¶÷¿¡°Ô´Â ¾ø°í ³ëÀο¡°Ô ¸¹´Ù. ±×·¯¹Ç·Î À̰ÍÀº ÅðÈ­ Çö»óÀ¸·Î »ý°¢µÇ¸ç, ¶Ç ³ú»çÀÇ ³»ºÎ¿¡´Â ÁÙ¹«´Ì°¡ ÀÖ´Â °ÍÀ¸·Î º¸¾Æ óÀ½¿¡´Â ÀÛÀº °ÍÀÌ Â÷Â÷ Ä¿Áø °ÍÀ̶ó »ý°¢µÈ´Ù. µ¿½É¼ºÀÇ Çϳª ÇϳªÀÇ ³ú»ç ÇüÅ´ ±¸»óÀÌ ¸¹°í, Ç¥¸éÀº »Í³ª¹« ¿­¸Å ¸ð¾çÀ¸·Î ¿ïÅüºÒÅüÇÏ´Ù. ³ú»ç°¡ ÁÖ¼ººÐÀ¸·Î µÇ¾î °áÇÕÁ¶Á÷À̳ª Ç÷°ü°ú ¹¶ÃÄÁø µ¢¾î¸®°¡ µå¹°°Ô ³úÀÇ ³»ºÎ ¶Ç´Â ±× °¡±îÀÌ¿¡ »ý±â´Â °æ¿ì°¡ ÀÖ´Ù. ±×°ÍÀ» ³ú»çÁ¾À̶ó Çϴµ¥, À̰Ϳ¡ ÀÇÇÏ¿© ³ú Á¶Á÷ÀÌ ¾Ð¹Ú ¶Ç´Â ÆÄ±«µÇ¸é ±×¿¡ µû¸£´Â Áõ¼¼°¡ ³ªÅ¸³­´Ù. ¸Å¿ì Å« ³ú»çÁ¾ÀÌ Á¦ 4³ú½Ç¿¡ »ý°Ü ¼ö¾×ÀÇ È帧À» ¹æÇØÇÏ´Â ¿¹µµ ÀÖ´Ù.
  • brain stem
    ³ú°£
    ´ë³ú ¹Ý±¸¸¦ ô¼ö¿Í ¿¬°áÇÏ´Â ½Å°æÁ¶Á÷À¸·Î¼­ ¿¬¼ö, ³ú±³ ¹× Áß³ú·Î ±¸¼ºµÇ¾î ÀÖ´Ù.
  • brain stem reflex
    ³ú°£ ¹Ý»ç
  • brain stem syndrome
    ³ú°£ ÁõÈıº
  • brain vesicle`s
    ³úÆ÷
    ¹èÅ ºÐÈ­ ½Ã¿¡ º¸ÀÌ´Â Æó¼â ½Å°æ°üÀÇ ´Ù¼¸ ºÎºÐ.
  • brain vesicle`s secondary
    ÀÌÂ÷ ³úÆ÷
    Èı⠹èÅ ºÐÈ­·Î Çü¼ºµÇ´Â ³× °³ÀÇ ³ú³¶À¸·Î¼­ Àü³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Á¾³ú¿Í °£³ú, ´É³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Èijú¿Í ¼ö³ú¸¦ Æ÷ÇÔÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
purpura, henoch-schonlein HSP is a form of blood vessel inflammation, a vasculitis that affects small arterial vessels in the skin (capillaries) and the kidneys. Hsp results in skin rash associated with joint inflammation (arthritis) and cramping pain in the abdomen. Hsp frequently follows a bacterial or viral infection of the throat or breathing passages and is an unusual reaction of the body's immune system to this infection. Hsp occurs most commonly in children. Hsp is generally a mild illness that resolves spontaneously, but sometimes it can cause serious problems in the kidneys and bowels. Treatment is directed toward the most significant area of involvement. Joint pain can be relieved by antiinflammatory medications, such as aspirin or ibuprofen. Some patients can require cortisone-related medications, such as prednisone, especially those with significant abdominal pain or kidney disease. Also known as anaphylactoid purpura.
(12 Dec 1998)
purpura, hyperglobulinaemic Purpura associated with an increase in gamma-globulins. The condition is no longer considered a specific entity since the clinical and laboratory findings are observed in a variety of haematologic conditions.
(12 Dec 1998)
purpura iodica Iodic purpura, an eruption of discrete miliary petechiae, usually confined to the lower extremities, appearing in rare instances on administration of any of the iodides.
(05 Mar 2000)
purpura nervosa <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
purpura pulicans Purpura pulicosa, petechiae caused by the bites of insects and animal parasites.
(05 Mar 2000)
purpura rheumatica <dermatology> This relatively rare disorder is characterised by skin purpura, joint pains, abdominal pain and renal disease (glomerulonephritis).
Although Henoch-Schonlein purpura or anaphylactoid purpura, is thought to be a immune complex mediated disease, its exact cause is unknown. Its typical benign coarse can, however, include renal failure.
(27 Sep 1997)
purpura, schoenlein-henoch A form of nonthrombocytopenic purpura due to a hypersensitivity vasculitis (vasculitis, hypersensitivity) associated with a variety of clinical symptoms including urticaria and erythema, arthropathy and arthritis, gastrointestinal symptoms, and renal involvement.
(12 Dec 1998)
purpura senilis The occurrence of petechiae and ecchymoses on the atrophic skin of the legs in aged and debilitated subjects.
(05 Mar 2000)
purpura simplex The eruption of petechiae or larger ecchymoses, usually unaccompanied by constitutional symptoms and not associated with systemic illness.
Synonym: nonthrombocytopenic purpura.
(05 Mar 2000)
purpura symptomatica A petechial eruption in scarlet fever and other exanthemas.
(05 Mar 2000)
purpura, thrombocytopenic Any form of purpura in which the platelet count is decreased. Many forms are thought to be caused by immunological mechanisms.
(12 Dec 1998)
purpura, thrombocytopenic, idiopathic Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IgG autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.
(12 Dec 1998)
purpura, thrombotic thrombocytopenic A disease characterised by thrombocytopenia, haemolytic anaemia, bizarre neurological manifestations, azotemia, fever, and thromboses in terminal arterioles and capillaries.
(12 Dec 1998)
purpura urticans Purpura simplex accompanied by an urticarial eruption.
(05 Mar 2000)
hyperglobulinaemic purpura <haematology> A condition characterised by proliferation of cells resembling lymphocytes or plasma cells in the bone marrow, anaemia, increased sedimentation rate and hyperglobulinaemia. Physical findings include mucosal bleeding, skin purpura and enlargement of the lymph nodes, liver and spleen.
Origin: Gr. Haima = blood
(27 Sep 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mechanical brain
    Àΰø µÎ³ú 
  • minimal brain dysfunction
    ¹Ì¼Ò ³ú±â´É Àå¾Ö (¾Æµ¿ÀÇ ÇнÀ Àå¾ÖÀÇ Çϳª)
  • right-brain
    ¿ì³ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á